US equities
|
MU
$1,035.84
▲+0.00%
SPCX
$160.57
▲+0.00%
NVDA
$230.48
▲+0.00%
AAPL
$340.42
▲+0.00%
SNDK
$1,609.46
▲+0.00%
INTC
$107.08
▲+0.00%
AMD
$620.68
▲+0.00%
LITE
$1,048.60
▲+0.00%
MU
$1,035.84
▲+0.00%
SPCX
$160.57
▲+0.00%
NVDA
$230.48
▲+0.00%
AAPL
$340.42
▲+0.00%
SNDK
$1,609.46
▲+0.00%
INTC
$107.08
▲+0.00%
AMD
$620.68
▲+0.00%
LITE
$1,048.60
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Metacrine, Inc. - Common Stock
(NQ:
MTCR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Metacrine, Inc. - Common Stock
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
December 23, 2022
From
Metacrine, Inc.
Via
GlobeNewswire
Metacrine Reports Third-Quarter 2022 Results
November 14, 2022
From
Metacrine, Inc.
Via
GlobeNewswire
METACRINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Metacrine Inc. - MTCR
October 04, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
METACRINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Metacrine Inc. - MTCR
September 07, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
MTCR Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Metacrine Inc. Is Fair to Shareholders
September 06, 2022
From
Halper Sadeh LLP
Via
Business Wire
Equillium to Acquire Metacrine in All-Stock Transaction
September 06, 2022
From
Equillium, Inc.
Via
Business Wire